Cargando…

NK cells in peripheral blood carry trogocytosed tumor antigens from solid cancer cells

The innate immune lymphocyte lineage natural killer (NK) cell infiltrates tumor environment where it can recognize and eliminate tumor cells. NK cell tumor infiltration is linked to patient prognosis. However, it is unknown if some of these antitumor NK cells leave the tumor environment. In blood-bo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campos-Mora, Mauricio, Jacot, William, Garcin, Genevieve, Depondt, Marie-Lise, Constantinides, Michael, Alexia, Catherine, Villalba, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427869/ https://www.ncbi.nlm.nih.gov/pubmed/37593736 http://dx.doi.org/10.3389/fimmu.2023.1199594

Ejemplares similares

When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer
por: Hasim, Mohamed S., et al.
Publicado: (2022)

Dissecting the NK Cell Population in Hematological Cancers Confirms the Presence of Tumor Cells and Their Impact on NK Population Function
por: Vo, Dang-Nghiem, et al.
Publicado: (2020)

CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis
por: Xu, Xiaozheng, et al.
Publicado: (2023)

Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers
por: Krzywinska, Ewelina, et al.
Publicado: (2015)

Differential trafficking of ligands trogocytosed via CD28 versus CTLA4 promotes collective cellular control of co-stimulation
por: Zenke, Simon, et al.
Publicado: (2022)

NK Cells Acquire CCR5 and CXCR4 by Trogocytosis in People Living with HIV-1
por: Vo, Dang-Nghiem, et al.
Publicado: (2022)

Direct Cell Death Induced by CD20 Monoclonal Antibodies on B Cell Lymphoma Cells Revealed by New Protocols of Analysis
por: Constantinides, Michael, et al.
Publicado: (2023)

The metabolism of cells regulates their sensitivity to NK cells depending on p53 status
por: Belkahla, Sana, et al.
Publicado: (2022)

Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells
por: Villalba, Martin, et al.
Publicado: (2020)

Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients
por: Reina-Ortiz, Chantal, et al.
Publicado: (2020)

CAR-NK Cells in the Treatment of Solid Tumors
por: Wrona, Ewa, et al.
Publicado: (2021)

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
por: Cantoni, Claudia, et al.
Publicado: (2016)

Antigen-specific NK cell memory in rhesus macaques
por: Reeves, R. Keith, et al.
Publicado: (2015)

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
por: Melaiu, Ombretta, et al.
Publicado: (2020)

NK cells and solid tumors: therapeutic potential and persisting obstacles
por: Tong, Le, et al.
Publicado: (2022)

Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers
por: Pfeifer Serrahima, Jordi, et al.
Publicado: (2023)

Assessment of NK Cell Activity Based on NK Cell-Specific Receptor Synergy in Peripheral Blood Mononuclear Cells and Whole Blood
por: Kim, Jung Min, et al.
Publicado: (2020)

NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice
por: Li, Dongping, et al.
Publicado: (2020)

P33. NK-92 cellular immunotherapy as an alternative to donor derived peripheral blood NK cells
por: Klingemann, H
Publicado: (2014)

Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis
por: Choreño-Parra, José Alberto, et al.
Publicado: (2021)

T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells
por: Kim, Hye-Ran, et al.
Publicado: (2018)

Re-discovering NK cell allo-reactivity in the therapy of solid tumors
por: Castagna, Luca, et al.
Publicado: (2016)

The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors
por: Velichinskii, Rodion A., et al.
Publicado: (2021)

Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors
por: Lian, Guangyu, et al.
Publicado: (2021)

Murine models to study human NK cells in human solid tumors
por: Parodi, Monica, et al.
Publicado: (2023)

Evaluation of the PIK3 pathway in peripheral T‐cell lymphoma and NK/T‐cell lymphoma
por: Huang, Dachuan, et al.
Publicado: (2020)

Proapoptotic Bim regulates antigen-specific NK cell contraction and the generation of the memory NK cell pool after cytomegalovirus infection
por: Min-Oo, Gundula, et al.
Publicado: (2014)

NK cells promote transplant tolerance by killing donor antigen-presenting cells
por: Yu, Guang, et al.
Publicado: (2006)

Controlling Cell Trafficking: Addressing Failures in CAR T and NK Cell Therapy of Solid Tumours
por: White, Lydia G., et al.
Publicado: (2022)

Phenotypic and Functional Plasticity of CXCR6(+) Peripheral Blood NK Cells
por: Angelo, Laura S., et al.
Publicado: (2022)

Extracellular matrix proteins regulate NK cell function in peripheral tissues
por: Bunting, Mark D., et al.
Publicado: (2022)

Rhinovirus Suppresses TGF-β-GARP Presentation by Peripheral NK Cells
por: Krammer, Susanne, et al.
Publicado: (2022)

The Role of O-Antigen in LPS-Induced Activation of Human NK Cells
por: Kanevskiy, Leonid M., et al.
Publicado: (2019)

Increased Numbers of NK Cells, NKT-Like Cells, and NK Inhibitory Receptors in Peripheral Blood of Patients with Chronic Obstructive Pulmonary Disease
por: Tang, Ying, et al.
Publicado: (2013)

NK Cells Equipped With a Chimeric Antigen Receptor That Overcomes Inhibition by HLA Class I for Adoptive Transfer of CAR-NK Cells
por: Zhuang, Xiaoxuan, et al.
Publicado: (2022)

Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
por: Moretta, Lorenzo, et al.
Publicado: (2014)

Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
por: Chen, Ziqing, et al.
Publicado: (2019)

Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment
por: Navin, Ishwar, et al.
Publicado: (2020)

Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT
por: Tumino, Nicola, et al.
Publicado: (2021)

Viral antigen mediated NKp46 activation of NK cells results in tumor rejection via NK-DC crosstalk
por: Chinnery, Fay, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0q37hmre67dkcpr163f2036rq7